Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

Heikenwalder, Mathias, Polymenidou, Magdalini, Junt, Tobias, Sigurdson, Christina, Wagner, Hermann, Akira, Shizuo, Zinkernagel, Rolf, Aguzzi, Adriano·2004·Nature Medicine

DOI 10.1038/nm987

Cited by (444)

Items 201–300 of 444

Cytokine and Ig‐production by CG‐containing sequences with phosphorodiester backbone and dumbbell‐shape
Manuel Schmidt, Katrin Anton, C. Nordhaus, Claas Junghans, B. Wittig, Margitta Worm · 2005 · Allergy
Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection
Jianmin Xue, Chiung-Yu Hung, Jieh‐Juen Yu, Garry T. Cole · 2005 · Vaccine
TLR-mediated immune activation in HIV
J. Judy Chang, Marcus A. Altfeld · 2009 · Blood
Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis
Liguo Zhang, Eric G. Meissner, Jianzhu Chen, LiShan Su · 2010 · Science China Life Sciences
CpG-DNA as immune response modifier
Alexander H. Dalpke, Klaus M. Heeg · 2004 · International Journal of Medical Microbiology
Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA
Dongbum Kim, Jae Won Rhee, Sanghoon Kwon, Wern‐Joo Sohn, Younghee Lee, Dae‐Won Kim, Doo‐Sik Kim, Hyung‐Joo Kwon · 2008 · Biochemical and Biophysical Research Communications
A Proviral Role for CpG in Cytomegalovirus Infection
Ann‐Charlotte Iversen, Bjørg Steinkjer, Nadra J. Nilsen, Janne Ø. Bohnhorst, Siv Helen Moen, Randi Vik, Phil J. Stephens, David Wayne Thomas, Chris A. Benedict, Terje Espevik · 2009 · The Journal of Immunology
Intact Type I Interferon Production and IRF7 Function in Sooty Mangabeys
Steven E. Bosinger, Zachary P. Johnson, Kathryn A. Folkner, Nirav Bipin Patel, Tayebeh Hashempour, Simon P. Jochems, Perla M. Del Río Estrada, Mirko Paiardini, Rongtuan Lin, Thomas H. Vanderford et al. · 2013 · PLoS Pathogens
Therapeutic Potential of Oligonucleotides Expressing Immunosuppressive TTAGGG Motifs
Dennis M. Klinman, İhsan Gürsel, Sven Klaschik, LI DONG, Debbie Currie, Hidekazu Shirota · 2005 · Annals of the New York Academy of Sciences
Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo
Svetlana Hamm, Antje Heit, Michael Koffler, Katharina Maria Huster, Shizuo Akira, Dirk Hans Busch, H. Wagner, Stefan Bauer · 2007 · International Immunology
Skin‐derived dendritic cells acquire and degrade the scrapie agent following in vitro exposure
Joanne Mohan, John Hopkins, Neil Andrew Mabbott · 2005 · Immunology
Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses
Tomoya Nagata, Toshiaki Toyota, Hirohito Ishigaki, Toru Ichihashi, Kiichi Kajino, Yoshitaka Kashima, Yasushi Itoh, Masahito Mori, Hiroshi Oda, Hiroyuki Yamamura et al. · 2007 · Vaccine
Is Genetic Vaccination against Allergy Possible?
Richard Weiss, Sandra Scheiblhofer, Maximilian Gabler, Fátima Ferreira, Wolfgang W. Leitner, Josef Thalhamer · 2006 · International Archives of Allergy and Immunology
IEIIS Meeting minireview: The role of innate immunity in the pathogenesis of asthma: evidence for the involvement of Toll-like receptor signaling
Nicolas W.J. Schröder, Moshe Arditi · 2007 · Journal of Endotoxin Research
Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization
Mariko Ishii, Naoya Kojima · 2009 · Glycoconjugate Journal
Outlining novel cellular adjuvant products for therapeutic vaccines against cancer
Josianne Nitcheu-Tefit, Vincent A. Serra · 2011 · Expert Review of Vaccines
Vaccine Approaches to Prevent and Treat Prion Infection
Andreas Müller‐Schiffmann, Carsten Korth · 2008 · BioDrugs
Microbial nucleic acids pay a Toll in kidney disease
Rahul D. Pawar, Prashant S. Patole, Markus Wörnle, Hans‐Joachim Anders · 2006 · American Journal of Physiology-Renal Physiology
Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides
Hideki Takahashi, Kazuki Misato, Taiki Aoshi, Yasuyuki Yamamoto, Yui Kubota, Xin Wu, Etsushi Kuroda, Ken J. Ishii, Hirofumi Yamamoto, Yasuo Yoshioka · 2018 · Frontiers in Immunology
Chronic Exposure to Type-I IFN under Lymphopenic Conditions Alters CD4 T Cell Homeostasis
Cécile Le Saout, Rebecca B. Hasley, Hiromi Imamichi, Lueng Tcheung, Zonghui Hu, Megan A. Luckey, Jung‐Hyun Park, Scott Kenneth Durum, Mindy Smith, Adam W. Rupert et al. · 2014 · PLoS Pathogens
Immunization with a Hemagglutinin-Derived Synthetic Peptide Formulated with a CpG-DNA-Liposome Complex Induced Protection against Lethal Influenza Virus Infection in Mice
Jae Won Rhee, Dongbum Kim, Byung Kwon Park, Sang‐Hoon Kwon, Sunhee Cho, Ilseob Lee, Man-Seong Park, Jae Nam Seo, Yong-Sun Kim, Hong Seok Choi et al. · 2012 · PLoS ONE
Mouse vaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapie
Véronique S. Bachy, Clara Ballerini, Pauline Gourdain, Aurélie Prignon, Saci Iken, Nadine Antoine, M. Bruley-Rosset, Claude Carnaud · 2009 · Journal of General Virology
Binding of CpG oligodeoxynucleotides to mesoporous silica nanoparticles for enhancing delivery efficiency
Cuilian Tao, Yufang Zhu, Xianglan Li, Nobutaka Hanagata · 2014 · Microporous and Mesoporous Materials
Multifunctional DNA Nanomaterials for Biomedical Applications
Dick Yan Tam, Pik Kwan Lo · 2015 · Journal of Nanomaterials
Emerging nanotechnologies for cancer immunotherapy
Sourabh Shukla, Nicole F. Steinmetz · 2016 · Experimental Biology and Medicine
Immunotherapy against Prion Disease
Yue Ma, Jiyan Ma · 2020 · Pathogens
The regulation and activation of lupus‐associated B cells
Michele L. Fields, Brian D. Hondowicz, Gina N. Wharton, Brigette S. Adair, Michele H. Metzgar, Shawn T. Alexander, Andrew J. Caton, Jan Erikson · 2005 · Immunological Reviews
Genuine Immunomodulation With dSLIM
Kerstin Kapp, Christiane Kleuss, Matthias Schroff, Burghardt Wittig · 2014 · Molecular Therapy — Nucleic Acids
The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells
V. Janovec, Besma Aouar, Albert Font-Haro, Tomáš Hofman, Kateřina Trejbalová, Jan Weber, Laurence Chaperot, Joël Plumas, Daniel Olive, Patrice C. Dubreuil et al. · 2018 · Frontiers in Immunology
Efficacy of Macrophage-activating Lipopeptide-2 Combined with Interferon-γ in a Murine Asthma Model
Henning Weigt, Christina Nassenstein, Thomas Tschernig, Peter F. Mühlradt, Norbert Krug, Armin C. Braun · 2005 · American Journal of Respiratory and Critical Care Medicine
Safety and Efficacy of Nasal Application of CpG Oligodeoxynucleotide as a Mucosal Adjuvant
Satoru Kodama, Nobuyuki Abe, Takashi Hirano, Masashi Suzuki · 2006 · The Laryngoscope
The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges
Ali M. Harandi · 2004 · Journal of Clinical Virology
The path ahead for understanding Toll-like receptor-driven systemic autoimmunity
Jessica A. Hamerman, Gregory M. Barton · 2024 · Current Opinion in Immunology
Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists
Olivia K. Burn, Kef Prasit, Ian F. Hermans · 2020 · Cancers
Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models
Marieke Robinet, Bérengère Villeret, Solène Maillard, Mélanie A. Cron, Sonia Berrih‐Aknin, Rozen Le Panse · 2017 · Frontiers in Immunology
Prevention and Therapy of Hepatocellular Carcinoma by Vaccination with TM4SF5 Epitope-CpG-DNA-Liposome Complex without Carriers
Sanghoon Kwon, Dongbum Kim, Byoung Kwon Park, Sunhee Cho, Kwang Dong Kim, Young‐Eun Kim, Cheung‐Seog Park, Hyun‐Jong Ahn, Jae-Nam Seo, Kyung‐Chan Choi et al. · 2012 · PLoS ONE
Effect of amino groups of mesoporous silica nanoparticles on CpG oligodexynucleotide delivery
Yi Xu, Peter Claiden, Yufang Zhu, Hiromi Morita, Nobutaka Hanagata · 2015 · Science and Technology of Advanced Materials
Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease
Eleanor Drummond, Fernando Goñi, Shan Liu, Frances Prelli, Henrieta Scholtzova, Thomas Wısnıewskı · 2018 · Journal of Alzheimer s Disease
Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells
Beatriz Domínguez-Molina, Kawthar Machmach, Celia Perales, Laura Tarancón‐Díez, Isabel Gallego, J. L. Sheldon, M. Leal, Esteban Domingo, Ezequiel Ruíz-Mateos · 2018 · Journal of Virology
CpG‐oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL‐8) production
Elena Nardini, Daniele Morelli, Piera Aiello, Dario Besusso, Claudia Calcaterra, Luigi Mariani, Marco Palazzo, Annunciata Vecchi, Saverio Paltrinieri, Sylvie Ménard et al. · 2005 · Journal of Cellular Physiology
Activation of Toll-like receptor 9 and production of epitope specific antibody by liposome-encapsulated CpG-DNA
Dongbum Kim, Hyung‐Joo Kwon, Younghee Lee · 2011 · BMB Reports
Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands
Victoria Y. Alfaro, David L. Goldblatt, Gabriella Valverde Ha, Mark F. Munsell, Lee J. Quinton, Adam K. Walker, Robert Dantzer, Atul Varadhachary, Brenton L. Scott, Scott E. Evans et al. · 2014 · Frontiers in Pharmacology
Oral pretreatment with β-lactoglobulin derived peptide and CpG co-encapsulated in PLGA nanoparticles prior to sensitizations attenuates cow’s milk allergy development in mice
Mengshan Liu, Suzan Thijssen, Wim E. Hennink, Johan Garssen, Cornelus F. van Nostrum, Linette E. M. Willemsen · 2023 · Frontiers in Immunology
Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies
Julia Karbach, Antje Neumann, Claudia Wahle, Kathrin Brand, Sacha Gnjatic, Elke Jäger · 2012 · Cancer Research
Repetitive Immunization Enhances the Susceptibility of Mice to Peripherally Administered Prions
Juliane Bremer, Mathias F Heikenwälder, Johannes Haybaeck, Cinzia Tiberi, Nike Julia Kräutler, Michael Odo Kurrer, Adriano Aguzzi · 2009 · PLoS ONE
Self‐Assembled DNA Nanostructures for Biomedical Applications
Linlin Song, Qiao Jiang, Zhen‐Gang Wang, Baoquan Ding · 2017 · ChemNanoMat
Vaccine protocols for enhanced immunogenicity of exogenous antigens
Antje Heit, Dirk Hans Busch, Hermann Wagner, Frank Schmitz · 2007 · International Journal of Medical Microbiology
CpG and LPS can interfere negatively with prion clearance in macrophage and microglial cells
Sabine Gilch, Frank Schmitz, Yasmine Aguib, Claudia Kehler, Sigrid Bülow, Stefan Bauer, Elisabeth Kremmer, Hermann M. Schätzl · 2007 · FEBS Journal
Cells and prions: A license to replicate
Mario Nuvolone, Adriano Aguzzi, Mathias F Heikenwälder · 2009 · FEBS Letters
Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9
Yuyi Zhang, Ang Lin, Cai Zhang, Zhigang Tian, Jian Zhang · 2014 · Cancer Immunology Immunotherapy
Toll-like receptor 2 confers partial neuroprotection during prion disease
Carroll, James A., Race, Brent, Williams, Katie, Chesebro, Bruce · 2018 · PLOS ONE
Adjuvant effect of liposome-encapsulated natural phosphodiester CpG-DNA
Dongbum Kim, Sanghoon Kwon, Chi-Seok Ahn, Younghee Lee, Soo‐Young Choi, Jinseu Park, Hyeok-Yil Kwon, Hyung‐Joo Kwon · 2011 · BMB Reports
Delivery of host cell-directed therapeutics for intracellular pathogen clearance
Michael A Collier, Matthew D. Gallovic, Kevin J. Peine, Anthony D. Duong, Eric M. Bachelder, John S. Gunn, Larry S. Schlesinger, Kristy M. Ainslie · 2013 · Expert Review of Anti-infective Therapy
Human hepatocytes depletion in the presence of HIV-1 infection in dual reconstituted humanized mice
Raghubendra Singh Dagur, Weimin Wang, Yan Cheng, Edward Makarov, Murali Ganesan, Hiroshi Suemizu, Catherine Gebhart, Santhi Gorantla, Natalia A. Osna, Larisa Y. Poluektova · 2018 · Biology Open
Inactivated Orf Virus Shows Antifibrotic Activity and Inhibits Human Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Replication in Preclinical Models
Daniela Paulsen, Andreas Urban, Andreas Knorr, Claudia Hirth‐Dietrich, Angela Siegling, Hans‐Dieter Volk, Andrew A. Mercer, Andreas Limmer, Beatrix Schumak, Percy Alexander Knolle et al. · 2013 · PLoS ONE
Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODN
Michelandrea De Cesare, Lucia Sfondrini, Manuela Campiglio, Michele Sommariva, Francesca Bianchi, Paola Perego, Nico van Rooijen, Rosanna Supino, Cristiano Rumio, Franco Zunino et al. · 2009 · Journal of Immunotherapy
Nanomaterial-assisted delivery of CpG oligodeoxynucleotides for boosting cancer immunotherapy
Zhiyu Zhang, Lu Yu, Wenjing Liu, Yuanyu Huang · 2024 · Journal of Controlled Release
The enduring tale of T cells in HIV immunopathogenesis.
Madhu Vajpayee, Neema Negi, Sravya Kurapati · 2013 · Europe PMC (PubMed Central)
Topical TLR9 agonists induce more efficient cross‐presentation of injected protein antigen than parenteral TLR9 agonists do
Hossain M. Najar, Jan Peter Dutz · 2007 · European Journal of Immunology
Use of nanoparticles to deliver immunomodulatory oligonucleotides
Dennis M. Klinman, Takashi Sato, Takeshi Shimosato · 2015 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
TLR9-Independent Activation of B Lymphocytes by Bacterial DNA
Xochitl Cortez‐Gonzalez, Ilenia Pellicciotta, Mara Gerloni, Matthew C. Wheeler, Paola Castiglioni, Petar S. Lenert, Maurizio Zanetti · 2006 · DNA and Cell Biology
Recent advances in prion biology
Adriano Aguzzi, Gino Miele · 2004 · Current Opinion in Neurology
Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity
Liu Shuan Yang, Yue Lang, Haoguang Wu, Kaiyan Xiang, Yuanzheng Wang, Mengqi Yu, Yu Liu, Bowei Yang, Liangcan He, Guangming Lu et al. · 2023 · ACS Nano
TLR-mediated up-regulation of serum retroviral gp70 is controlled by the Sgp loci of lupus-prone mice
Lucie Baudino, Kumiko Yoshinobu, Isabelle Dunand-Sauthier, Leonard H. Evans, Shozo Izui · 2010 · Journal of Autoimmunity
A novel triple adjuvant formulation promotes strong, Th1-biased immune responses and significant antigen retention at the site of injection
Heather L. Wilson, Jennifer Kovacs-Nolan, Laura J. P. Latimer, Rachelle M. Buchanan, Susantha M. Gomis, Lorne A. Babiuk, Sylvia van Drunen Littel‐van den Hurk · 2010 · Vaccine
Vaccination With Trifunctional Nanoparticles That Address CD8 + Dendritic Cells Inhibits Growth of Established Melanoma
Limei Shen, Susanne Krauthäuser, Karl Fischer, Dominika Hobernik, Yasmin Abassi, Andrzej Dzionek, Alexej Nikolaev, Nicole Voltz, Mustafa Diken, Mathias Krummen et al. · 2016 · Nanomedicine
Targeting Lymph Node Sinus Macrophages to Inhibit Lymph Node Metastasis
Junqing Hu, Jinhao Xu, Mingyue Li, Yanping Zhang, Huaiqiang Yi, Jiangning Chen, Lei Dong, Junfeng Zhang, Zhen Dong Huang · 2019 · Molecular Therapy — Nucleic Acids
Future horizons in Alzheimer's disease research
Thomas Wısnıewskı, Eleanor Drummond · 2019 · Progress in molecular biology and translational science
The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis
Neil Andrew Mabbott, Barry Matthew Bradford, Reiss Pal, Rachel A Young, David S. Donaldson · 2020 · International Journal of Molecular Sciences
A Palindromic CpG-Containing Phosphodiester Oligodeoxynucleotide as a Mucosal Adjuvant Stimulates Plasmacytoid Dendritic Cell-Mediated TH1 Immunity
Jun‐ichi Maeyama, Hisakazu Takatsuka, Fumiko Suzuki, Ayumi Kubota, Satomi Horiguchi, Takako Komiya, Ichiroh Shimada, Eri Murata, Youko Osawa, Harukazu Kitagawa et al. · 2014 · PLoS ONE
Cytokine/Stromal Cell Networks and Lymphoid Tissue Environments
Jörg Hermann Fritz, Jennifer L. Gommerman · 2010 · Journal of Interferon & Cytokine Research
Cyclooxygenase-2 Inhibition Promotes Enhancement of Antitumor Responses by Transcutaneous Vaccination with Cytosine-Phosphate-Guanosine-Oligodeoxynucleotides and Model Tumor Antigen
Joe Inoue, Yukihiko Aramaki · 2006 · Journal of Investigative Dermatology
Local and Systemic Effects of Intranodally Injected CpG-C Immunostimulatory-Oligodeoxyribonucleotides in Macaques
Natalia Teleshova, Jessica Kenney, Gary Van Nest, Jason D. Marshall, Jeffrey D. Lifson, Irving Sivin, Jason Dufour, Rudolf P. Bohm, Agegnehu Gettie, Melissa Robbiani · 2006 · The Journal of Immunology
CpG Immunostimulatory Sequences Enhance Contact Hypersensitivity Responses in Mice
Hitoshi Akiba, Masataka Satoh, Keiji Iwatsuki, Dominique Kaiserlian, Jean‐François Nicolas, Fumio Kaneko · 2004 · Journal of Investigative Dermatology
Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome
Mathilde Harel, Charlotte Girard-Guyonvarc’h, Emiliana Rodriguez, Gaby Palmer, Cem Gabay · 2020 · The Journal of Immunology
Evaluating the Accelerated Blood Clearance Phenomenon of PEGylated Nanoemulsions in Rats by Intraperitoneal Administration
Yuqing Su, Mengyang Liu, Kaifan Liang, Xinrong Liu, Yanzhi Song, Yihui Deng · 2018 · AAPS PharmSciTech
Lipid Nanoparticle with 1,2-Di-O-octadecenyl-3-trimethylammonium-propane as a Component Lipid Confers Potent Responses of Th1 Cells and Antibody against Vaccine Antigen
Atsushi Kawai, Masahiro Noda, Haruki Hirata, Lisa Munakata, Teppei Matsuda, Daiki Omata, Naoki Takemura, Sakura Onoe, Mika Hirose, Takayuki Kato et al. · 2024 · ACS Nano
Liposome-Encapsulated CpG Enhances Antitumor Activity Accompanying the Changing of Lymphocyte Populations in Tumor via Intratumoral Administration
Dong Hyeok Kim, Chaerin Moon, Sang‐Seok Oh, Soojong Park, Jin-Woo Jeong, Suk Kim, Hee Gu Lee, Hyung‐Joo Kwon, Kwang Dong Kim · 2015 · Nucleic Acid Therapeutics
Synthetic Poly(l-Glutamic Acid)-conjugated CpG Exhibits Antitumor Efficacy With Increased Retention in Tumor and Draining Lymph Nodes After Intratumoral Injection in a Mouse Model of Melanoma
Qing Ma, Dapeng Zhou, Elizabeth S. DeLyria, Xiaoxia Wen, Wei Lü, Prakash Thapa, Chengwen Liu, Dan Li, Roland L. Bassett, Willem W. Overwijk et al. · 2016 · Journal of Immunotherapy
Th2-polarised PrP-specific Transgenic T-cells Confer Partial Protection against Murine Scrapie
Saci Iken, Véronique S. Bachy, Pauline Gourdain, Annick Lim, Sylvie Grégoire, Thomas Chaigneau, Pièrre Aucouturier, Claude Carnaud · 2011 · PLoS Pathogens
Immunological and pathological responses in BALB/c mice induced by genetic administration ofTc13 Tul antigen ofTrypanosoma cruzi
Gabriela Andrea García, María Rosa Arnaiz, Susana Adriana Laucella, Mónica I. Esteva, Natalia Ainciart, Adelina Rosa Riarte, Patricia Andrea Garavaglia, Laura Edith Fichera, A. M. RUIZ · 2006 · Parasitology
A critical role for IL‐15 in TLR‐mediated innate antiviral immunity against genital HSV‐2 infection
Amit Thatte, Stephanie J. DeWitte‐Orr, Brian Dennis Lichty, Karen Louise Mossman, Ali A. Ashkar · 2011 · Immunology and Cell Biology
Impact of prophylactic CpG Oligodeoxynucleotide application on implant-associated Staphylococcus aureus bone infection
Shneh Sethi, Ulrich Thormann, Ursula Sommer, Sabine Stötzel, Walid A. Mohamed, Reinhard Schnettler, Eugen Domann, Trinad Chakraborty, Volker Alt · 2015 · Bone
An Oligodeoxynucleotide with Promising Modulation Activity for the Proliferation and Activation of Osteoblast
Zhiyuan Feng, Yuqin Shen, Liying Wang, Lin Cheng, Jing Wang, Quanshun Li, Wei Shi, Xinhua Sun · 2011 · International Journal of Molecular Sciences
Oral administration of poly‐γ‐glutamic acid prevents the development of atopic dermatitis in NC / N ga mice
Sung Won Lee, Hyun Jung Park, Se‐Ho Park, Seokmann Hong · 2013 · Experimental Dermatology
Improved systemic pharmacokinetics, biodistribution, and antitumor activity of CpG oligodeoxynucleotides complexed to endogenous antibodies in vivo
Enzo Palma, Moo J. Cho · 2007 · Journal of Controlled Release
Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas
E T Akporiaye, D Bradley-Dunlop, Sandra J Gendler, Pinku Mukherjee, Cathy S. Madsen, Tobias Hahn, David G. Besselsen, Sharon M. Dial, Haiyan Cui, Katrina T. Trevor · 2007 · Vaccine
CpG ODN/Mangiferin Dual Delivery through Calcium Alginate Hydrogels Inhibits Immune-Mediated Osteoclastogenesis and Promotes Alveolar Bone Regeneration in Mice
Yingzhi Gu, Yang Hu, Shengyuan Huang, Sunniva Ruiz, Toshihisa Kawai, Yuxing Bai, Xiaozhe Han · 2023 · Biology
Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy
Tingting Jiang, Zailin Yang, Qiuyu Su, Liang Fang, Qing Xiang, Tian Cheng, Qinlin Gao, Chengde Mao, Cheng Zhi Huang, Hua Zuo · 2025 · ACS Applied Materials & Interfaces
Induction of immunological memory response by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex in a mouse hepatocellular carcinoma model
Sanghoon Kwon, Dongbum Kim, Byoung Kwon Park, Guang Jer Wu, Min‐Chul Park, Yang-Wha Ha, Hyung‐Joo Kwon, Younghee Lee · 2012 · Oncology Reports
Effect of Immunoglobin-Like Transcript 7 Cross-Linking on Plasmacytoid Dendritic Cells Differentiation into Antigen-Presenting Cells
Barbara Tavano, Adriano Boasso · 2014 · PLoS ONE
Therapeutic interventions ameliorating prion disease
Marcus W. Brazier, Vanessa A Wall, Barry W Brazier, Colin Louis Masters, Steven John Collins · 2009 · Expert Review of Anti-infective Therapy
Adjuvant Properties of CpG Oligonucleotides in Primates
Daniela I. Verthelyi · 2006 · Humana Press eBooks
A Unique Mucin Immunoenhancing Peptide with Antitumor Properties
Lynn M. Herbert, Joseph F. Grosso, Mantley Dorsey, Tihui Fu, Iafa Keydar, Mabel A. Cejas, Daniel H. Wreschner, Nechama I. Smorodinsky, Diana M. Lopez · 2004 · Cancer Research
Tuning DNA Dissociation from Spherical Nucleic Acids for Enhanced Immunostimulation
Jasper W. Dittmar, Michelle H. Teplensky, Michael Evangelopoulos, Lei Qin, Bin Zhang, Chad Alexander Mirkin · 2023 · ACS Nano
Immune Activation and the Role of TLRs and TLR Agonists in the Pathogenesis of HIV-1 Infection in the Humanized Mouse Model
J. Judy Chang, Marcus A. Altfeld · 2013 · The Journal of Infectious Diseases
Perspective of Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers
Younghee Lee, Young Seek Lee, Soo Young Cho, Hyung‐Joo Kwon · 2015 · Advances in protein chemistry and structural biology
Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection
Allison K. Ehrlich, Olga Lucía Fernández, Daniel Rodríguez‐Pinto, Tiago Moreno Castilho, Maria J. Corral Caridad, Karen Goldsmith‐Pestana, Nancy Gore Saravia, Diane McMahon‐Pratt · 2017 · Infection and Immunity
Contribution of Antibody and T Cell-Specific Responses to the Progression of 139A-Scrapie in C57BL/6 Mice Immunized with Prion Protein Peptides
Antoine Sacquin, Anne‐Sophie Bergot, Pièrre Aucouturier, M. Bruley-Rosset · 2008 · The Journal of Immunology
Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies
Christian J. Buchholz, Patricia Bach, Daphne Nikles, Ulrich Kalinke · 2006 · Expert Opinion on Biological Therapy